Evidence map›Paper›PMID 31293733›Full record

ArticleChemical science2019

Multiplexed immunophenotyping of circulating exosomes on nano-engineered ExoProfile chip towards early diagnosis of cancer.

Peng Zhang, Xin Zhou, Yong Zeng

Abstract read
In one paragraph

Article in Chemical science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Exosomes in Cancer: Diagnostic and Therapeutic Applications.Clinical Medicine Insights. Oncology · 2024
    Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Peng ZhangDepartment of Chemistry , Ralph N Adams Institute for Bioanalytical Chemistry , University of Kansas , Lawrence , KS 66045 , USA . Email: yongz@ku.edu.
Xin ZhouDepartment of Chemistry , Ralph N Adams Institute for Bioanalytical Chemistry , University of Kansas , Lawrence , KS 66045 , USA . Email: yongz@ku.edu.
Yong ZengDepartment of Chemistry , Ralph N Adams Institute for Bioanalytical Chemistry , University of Kansas , Lawrence , KS 66045 , USA . Email: yongz@ku.edu.ORCID 0000-0003-0537-109X

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SUSAN J. BROWN · 2012 to 2026
$63.0M
Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NICOLE L NOLLEN · 2012 to 2026
$40.1M
Understanding the mechanobiology of stem cells in a microengineered 3D cardiac tissue environment with cardiomyopathyP20GM103638 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI HOLMSTROM, ERIK D · 2012 to 2021
$22.1M
Integrated exosomes profiling for minimally invasive diagnosis and monitoring of cancerR33CA214333 · NCI · UNIVERSITY OF KANSAS LAWRENCE · PI GODWIN, ANDREW K., SAMUEL, GLENSON · 2017 to 2019
$1.2M
Integrated Microfluidic Exosome Profiling for Early Detection of CancerR21CA186846 · NCI · UNIVERSITY OF KANSAS LAWRENCE · PI ZENG, YONG · 2014 to 2016
$645k
Integrated Digital Microfluidic Platforms for Next-Generation GlycomicsR21CA207816 · NCI · UNIVERSITY OF KANSAS LAWRENCE · PI ZENG, YONG · 2016 to 2017
$585k
Microfluidic Integrative Circulating miRNA Profiling for Cancer DiagnosisR21EB024101 · NIBIB · UNIVERSITY OF KANSAS LAWRENCE · PI DOYLE, PATRICK S, ZENG, YONG · 2017 to 2018
$411k
NCI NIH HHS P30 CA168524NCI NIH HHS R21 CA186846NCI NIH HHS R21 CA207816NCI NIH HHS R33 CA214333NIBIB NIH HHS R21 EB024101NIGMS NIH HHS P20 GM103418NIGMS NIH HHS P20 GM103638
6 · The paper itself

Abstract

Circulating exosomes have been studied as a promising biomarker for non-invasive cancer diagnosis, as they are implicated in tumor initiation, progression, and metastasis. However, the clinical significance of circulating exosomes has not been revealed thoroughly, due to the technical limitation in sensitive and multiplexed detection of cargoes on exosomes, such as proteins and nucleic acids. Herein we developed an integrated exosome profiling platform (ExoProfile chip) to afford superior sensitivity and multiplexed capability for quantitative detection of a panel of surface protein markers on exosomes. To achieve this goal, we innovatively constructed 3D porous serpentine nanostructures

Identifiers

PMID31293733
PMCPMC6544119

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.